TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

  • Leukemia. 2020 Sep;34(9):2498-2502. doi: 10.1038/s41375-020-0759-3.
Eva Szenes   #  1 ,  Andrea Härzschel   #  1  2 ,  Sarah Decker  2 ,  Erika Tissino  3 ,  Justine Pischeli  1 ,  Julia Christine Gutjahr  1 ,  Sandra Kissel  2 ,  Sandra Pennisi  2 ,  Jan Philip Höpner  1 ,  Alexander Egle  1 ,  Nadja Zaborsky  1 ,  Christine Dierks  2 ,  Marie Follo  2 ,  Alexandre Chigaev  4 ,  Antonella Zucchetto  3 ,  Richard Greil  1 ,  Valter Gattei  3 ,  Tanja Nicole Hartmann  5  6
Affiliations
  • 1. Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • 2. Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • 3. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • 4. Department of Pathology and Cancer Center, University of New Mexico, Albuquerque, NM, USA.
  • 5. Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria. [email protected].
  • 6. Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany. [email protected].
  • # Contributed equally.
PMID: 32086446 DOI: 10.1038/s41375-020-0759-3
Products